• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ERA Biotech

edit

ERA Biotech develops and implements next-generation, cell-based biomanufacturing technologies. Our Zera® and StorPro® tools enable performance gains in most standard eukaryotic culture systems used today for production of protein drugs, enzymes and other biological products.

Milestones

edit

• 
  ERA Biotech added François Arcand as CEO.
  Posted 6/9/09 at 11:15pm
• 
  ERA Biotech received $1.85M (€1.4M) in Venture Round funding. (11/30/06)
  Posted 4/29/10 at 1:28am via erabiotech.com
• 
  ERA Biotech received $5.3M in Series B funding. (9/16/09)
  Posted 9/24/09 at 1:58pm via erabiotech.com
• 
  ERA Biotech received $6.18M in Venture Round funding. (6/3/08)
  Posted 6/9/09 at 11:15pm

Videos

Screenshots

edit

Above: Homepage
Uploaded: 6/10/09

Sources

1. ERA BIOTECH CONCLUDES €1.4M FINANCING ROUND (erabiotech.com) [edit]
2. Capital Funding Report [edit]
3. ERA BIOTECH ANNOUNCES A €3,75m ($5,3m) EQUITY FINANCING BY INTERNATIONAL AND SPANISH INVESTORS (erabiotech.com) [edit]